In this episode of Talking O&G: a RANZCOG Podcast, host A/Prof Roshan Zeirideen Zaid speaks to Dr Naomi Holbeach about the ethics of use of novel technology and surgical innovation in obstetric and gynaecological practice.  

Dr Holbeach is an obstetrician and gynaecologist who holds a law degree and a PhD in bioethics. A/Prof Zeirideen Zaid and Dr Holbeach examine the legal, professional, and moral obligations held by medical practitioners, and how to align these with clinical decision making in the use of innovative technology, techniques, or devices.  

Dr Holbeach shares advice for clinicians wishing to engage in novel technology and surgical innovation to continue to improve care and provide more options for their patients. She highlights the importance of instilling informed consent and collaboration into all stages of the innovation process. 

🔗 Resources mentioned in this episode: 

📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733  

💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. 

RANZCOG acknowledges the need for more inclusive terminology for gender diversity. In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care.   

The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).

In this episode of Talking O&G: a RANZCOG Podcast, host A/Prof Roshan Zeirideen Zaid speaks to Dr Naomi Holbeach about the ethics of use of novel technology and surgical innovation in obstetric and gynaecological practice.  

Dr Holbeach is an obstetrician and gynaecologist who holds a law degree and a PhD in bioethics. A/Prof Zeirideen Zaid and Dr Holbeach examine the legal, professional, and moral obligations held by medical practitioners, and how to align these with clinical decision making in the use of innovative technology, techniques, or devices.  

Dr Holbeach shares advice for clinicians wishing to engage in novel technology and surgical innovation to continue to improve care and provide more options for their patients. She highlights the importance of instilling informed consent and collaboration into all stages of the innovation process. 

🔗 Resources mentioned in this episode: 

📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733  

💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. 

RANZCOG acknowledges the need for more inclusive terminology for gender diversity. In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care.   

The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).

In this episode of Talking O&G: a RANZCOG Podcast, host Dr Cecile Bergzoll speaks with Dr Silipa Naiqiso and Dr Sathana Ponnampalam about the rising rates of endometrial cancer in Aotearoa New Zealand.  

Cases of endometrial cancer are rising globally, and Aotearoa New Zealand has some of the fastest-rising rates in the world. However, there are significant barriers to care due to a lack of funding for areas such as diagnosis, molecular-directed care, and immunotherapy. Dr Naiqiso and Dr Ponnampalam examine these barriers, the strategies being developed to address the crisis, and advice for clinicians.  

They explore the changing demographic of women impacted by endometrial cancer and the equity gaps that exist for Māori and Pacific women. Dr Naiqiso and Dr Ponnampalam stress the need for a public awareness campaign in addition to advocating for funding to improve access to diagnosis and care in Aotearoa.  

🔗 Resources mentioned in this episode: 

📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733  

💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. 

RANZCOG acknowledges the need for more inclusive terminology for gender diversity. In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care.   

The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).

In this episode of Talking O&G: a RANZCOG Podcast, host Dr Cecile Bergzoll speaks with Dr Silipa Naiqiso and Dr Sathana Ponnampalam about the rising rates of endometrial cancer in Aotearoa New Zealand.  

Cases of endometrial cancer are rising globally, and Aotearoa New Zealand has some of the fastest-rising rates in the world. However, there are significant barriers to care due to a lack of funding for areas such as diagnosis, molecular-directed care, and immunotherapy. Dr Naiqiso and Dr Ponnampalam examine these barriers, the strategies being developed to address the crisis, and advice for clinicians.  

They explore the changing demographic of women impacted by endometrial cancer and the equity gaps that exist for Māori and Pacific women. Dr Naiqiso and Dr Ponnampalam stress the need for a public awareness campaign in addition to advocating for funding to improve access to diagnosis and care in Aotearoa.  

🔗 Resources mentioned in this episode: 

📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733  

💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. 

RANZCOG acknowledges the need for more inclusive terminology for gender diversity. In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care.   

The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).

In this episode of Talking O&G: a RANZCOG Podcast, host Dr Vijaya Karanam speaks to obstetrician Dr Penny Sheehan, consumer Yvonne Maringa, and midwife Deborah Pidd about the vital role informed consent plays in everyday clinical practice. 

They outline the fundamentals of the recently released signposting guideline Consent and provision of information to patients regarding proposed treatments (C-Gen 2). Dr Sheehan and Ms Pidd discuss the responsibilities of clinicians to ensure patients are informed, respected, and feel empowered to ask questions and engage in shared decision-making. They emphasise that consent is relational, not transactional, and establishing a relationship of trust is essential. 

Ms Maringa shares what good informed consent looks like and means to the patient, and how clinicians can help them to feel informed and safe even in high-pressure, time-sensitive situations.  

They all highlight the importance of patient-centred, culturally responsive, and individualised care as core aspects of embedding informed consent into practice.  

🔗 Resources mentioned in this episode: 

📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733  

💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. 

RANZCOG acknowledges the need for more inclusive terminology for gender diversity. In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care.   

The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).

In this episode of Talking O&G: a RANZCOG Podcast, host Dr Vijaya Karanam speaks to obstetrician Dr Penny Sheehan, consumer Yvonne Maringa, and midwife Deborah Pidd about the vital role informed consent plays in everyday clinical practice. 

They outline the fundamentals of the recently released signposting guideline Consent and provision of information to patients regarding proposed treatments (C-Gen 2). Dr Sheehan and Ms Pidd discuss the responsibilities of clinicians to ensure patients are informed, respected, and feel empowered to ask questions and engage in shared decision-making. They emphasise that consent is relational, not transactional, and establishing a relationship of trust is essential. 

Ms Maringa shares what good informed consent looks like and means to the patient, and how clinicians can help them to feel informed and safe even in high-pressure, time-sensitive situations.  

They all highlight the importance of patient-centred, culturally responsive, and individualised care as core aspects of embedding informed consent into practice.  

🔗 Resources mentioned in this episode: 

📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733  

💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. 

RANZCOG acknowledges the need for more inclusive terminology for gender diversity. In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care.   

The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).

In this episode of Talking O&G: a RANZCOG Podcast, host A/Prof Roshan Zeirideen Zaid speaks to Dr Keeth Mayakaduwage and Dr Penny Sheehan about the impacts and implementation of the Safer Baby Bundle, Australia’s national initiative to reduce the number of stillborn babies by 20%.  

Dr Mayakaduwage and Dr Sheehan outline the context of stillbirth in Australia and the targets of the Safer Baby Bundle. They examine the key components of the bundle, including its cultural adaptations for First Nations and migrant and refugee communities.  

Dr Mayakaduwage presents the central findings of an ANZJOG research series which examined the early impacts of the bundle in Victoria, on which he was lead author. Dr Sheehan shares her experience implementing the bundle in clinical practice and provides recommendations for clinicians wishing to strengthen its impact in their own jurisdictions.  

🔗 Resources mentioned in this episode: 

📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733  

💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. 

RANZCOG acknowledges the need for more inclusive terminology for gender diversity. In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care.   

The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).

In this episode of Talking O&G: a RANZCOG Podcast, host A/Prof Roshan Zeirideen Zaid speaks to Dr Keeth Mayakaduwage and Dr Penny Sheehan about the impacts and implementation of the Safer Baby Bundle, Australia’s national initiative to reduce the number of stillborn babies by 20%.  

Dr Mayakaduwage and Dr Sheehan outline the context of stillbirth in Australia and the targets of the Safer Baby Bundle. They examine the key components of the bundle, including its cultural adaptations for First Nations and migrant and refugee communities.  

Dr Mayakaduwage presents the central findings of an ANZJOG research series which examined the early impacts of the bundle in Victoria, on which he was lead author. Dr Sheehan shares her experience implementing the bundle in clinical practice and provides recommendations for clinicians wishing to strengthen its impact in their own jurisdictions.  

🔗 Resources mentioned in this episode: 

📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733  

💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. 

RANZCOG acknowledges the need for more inclusive terminology for gender diversity. In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care.   

The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).

In this episode of Talking O&G: a RANZCOG Podcast, host Dr Anna Clare speaks with Conj A/Prof Tania Day about gynaecologists' role in prevention of vulvar squamous cell carcinoma by identifying and treating vulvar intraepithelial neoplasia (VIN) and distinguishing these from benign squamous intraepithelial lesions (SIL). They unpack the recently published 2026 International Society for the Study of Vulvovaginal Disease (ISSVD) terminology guide, on which Conj A/Prof Day was lead author.  

The ISSVD terminology was last updated in 2015, and there have since been major advancements in the clinical understanding of VIN histopathology and immunohistochemistry. Dr Clare and Conj A/Prof Day examine these developments, outlining the new preferred terminology, as well as diagnosis, treatment, and follow up. They highlight the importance of consistent language to aid collective efforts in vulval cancer elimination.  

🔗 Resources mentioned in this episode: 

📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733  

💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. 

RANZCOG acknowledges the need for more inclusive terminology for gender diversity. In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care.   

The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).

In this episode of Talking O&G: a RANZCOG Podcast, host Dr Anna Clare speaks with Conj A/Prof Tania Day about gynaecologists' role in prevention of vulvar squamous cell carcinoma by identifying and treating vulvar intraepithelial neoplasia (VIN) and distinguishing these from benign squamous intraepithelial lesions (SIL). They unpack the recently published 2026 International Society for the Study of Vulvovaginal Disease (ISSVD) terminology guide, on which Conj A/Prof Day was lead author.  

The ISSVD terminology was last updated in 2015, and there have since been major advancements in the clinical understanding of VIN histopathology and immunohistochemistry. Dr Clare and Conj A/Prof Day examine these developments, outlining the new preferred terminology, as well as diagnosis, treatment, and follow up. They highlight the importance of consistent language to aid collective efforts in vulval cancer elimination.  

🔗 Resources mentioned in this episode: 

📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733  

💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. 

RANZCOG acknowledges the need for more inclusive terminology for gender diversity. In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care.   

The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).